Mesothelioma - 56 Studies Found
| Completed |
: Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed : Malignant Mesothelioma : 2000-01-28 : Drug: raltitrexed |
| Completed |
: Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma : Malignant Mesothelioma : 2007-04-09 :
|
| Completed |
: SU5416 in Treating Patients With Malignant Mesothelioma : Malignant Mesothelioma : 2000-07-05 : Drug: semaxanib |
| Completed |
: Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma : Malignant Mesothelioma : 2007-07-30 : Drug: dasatinib 50 mg PO bid |
| Completed |
: PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma : Malignant Mesothelioma : 2003-02-05 : Drug: PTK787/ZK 222584 oral |
| Completed |
: S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery : Malignant Mesothelioma : 1999-11-01 : Drug: gemcitabine hydrochloride Gemcitabine 1000 mg/m^2 days 1, 8 15 (q 28 days) |
| Completed |
: A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma : Malignant Mesothelioma : 2012-07-18 : Drug: Tremelimumab Given IV Other Name: CP-675,206 |
| Completed |
: Capecitabine in Treating Patients With Malignant Mesothelioma : Malignant Mesothelioma : 2000-01-21 : Drug: capecitabine |
| Terminated |
: Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma : Malignant Mesothelioma : 2001-12-07 : Drug: trabectedin |
| Terminated |
: The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma : Malignant Mesothelioma : 2012-07-31 : Drug: Tremelimumab Tremelimumab is administered as endovenous infusion |